Imiquimod Leman 5% crema Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

imiquimod leman 5% crema

leman skl sa - imiquimodum - crema - imiquimodum 50 mg, acidum isostearicum, alcohol benzylicus 20 mg, e 218 2 mg, propylis parahydroxybenzoas 0.2 mg, alcohol cetylicus 22 mg, alcohol stearylicus 31 mg, vaselinum album, sorbitani stearas, polysorbatum 60, glycerolum, xanthani gummi, aqua purificata, ad emulsionem pro 1 g. - immunomodulateur - synthetika

Aldara Unione Europea - italiano - EMA (European Medicines Agency)

aldara

viatris healthcare limited - imiquimod - condylomata acuminata; keratosis; keratosis, actinic; carcinoma, basal cell - antibiotici e chemioterapici per uso dermatologico - imiquimod cream is indicated for the topical treatment of :external genital and perianal warts (condylomata acuminata) in adults. small superficial basal cell carcinomas (sbccs) in adults. clinically typical, nonhyperkeratotic, nonhypertrophic actinic keratoses (aks) on the face or scalp in immunocompetent adult patients when size or number of lesions limit the efficacy and/or acceptability of cryotherapy and other topical treatment options are contraindicated or less appropriate.

Zyclara Crema Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

zyclara crema

viatris pharma gmbh - imiquimodum - crema - imiquimodum 37.5 mg, acidum isostearicum, alcohol benzylicus 20.0 mg, alcohol cetylicus 22.0 mg, alcohol stearylicus 31.0 mg, vaselinum album, polysorbatum 60, sorbitani stearas, glycerolum, xanthani gummi, e 218 2.0 mg, propylis parahydroxybenzoas 0.2 mg, aqua purificata, ad emulsionem pro 1 g. - cheratosi attinica (non hyperkeratotisch); second-line - synthetika

Aldara 5 % Crema Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

aldara 5 % crema

viatris pharma gmbh - imiquimodum - crema - imiquimodum 50 mg, acidum isostearicum, alcohol cetylicus 22 mg, alcohol stearylicus 31 mg, vaselinum album, polysorbatum 60, sorbitani stearas, alcohol benzylicus 20 mg, e 218 2 mg, propylis parahydroxybenzoas 0.2 mg, glycerolum, xanthani gummi, aqua purificata, ad emulsionem pro 1 g. - immunmodulator - synthetika

Zyclara Unione Europea - italiano - EMA (European Medicines Agency)

zyclara

viatris healthcare limited - imiquimod - keratosis; keratosis, actinic - antibiotici e chemioterapici per uso dermatologico - zyclara è indicato per il trattamento topico di keratosis attinico clinicamente tipico, non ipercheratosiche, non ipertrofica, visibile o palpabile del viso completo o calvizie del cuoio capelluto negli adulti immunocompetenti, quando altre opzioni di trattamento topico sono controindicata o meno appropriato.